1374 / 1601
ESTRO IG and Adaptive Course
Parikh Budapest 2018
Dose escalation may improve SURVIVAL in
Pancreatic Cancer
Retrospective report from
MD Anderson
Tumors at least 1 cm from
a GI structure (25% of
patients) were
considered for
hypofractionated dose
escalation
Patients who received
radiotherapy with BED
> 70 Gy had an
improved overall
survival of 36% versus
19% at 2 years, and 31%
versus 9% at 3 years
Krishnan et
al, IJROBP,
Moningi et al,
Ann Surg